As of 2026-10-05, the Relative Valuation of 4D Molecular Therapeutics Inc (FDMT) is (93.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.67 USD, the upside of 4D Molecular Therapeutics Inc based on Relative Valuation is -781.9%.
The range of the Relative Valuation is (85.68) - (99.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 29.1x | 27.0x |
| Forward P/E multiples | 25.0x - 29.8x | 27.4x |
| Fair Price | (85.68) - (99.73) | (93.22) |
| Upside | -726.8% - -829.6% | -781.9% |
| Date | P/E |
| 2026-10-02 | -3.99 |
| 2026-10-01 | -4.04 |
| 2026-09-30 | -4.18 |
| 2026-09-29 | -4.23 |
| 2026-09-28 | -4.25 |
| 2026-09-25 | -4.22 |
| 2026-09-24 | -4.29 |
| 2026-09-23 | -4.38 |
| 2026-09-22 | -4.63 |
| 2026-09-21 | -4.45 |
| 2026-09-18 | -4.44 |
| 2026-09-17 | -4.28 |
| 2026-09-16 | -4.01 |
| 2026-09-15 | -3.98 |
| 2026-09-14 | -4.01 |
| 2026-09-11 | -3.84 |
| 2026-09-10 | -3.94 |
| 2026-09-09 | -4.14 |
| 2026-09-08 | -4.27 |
| 2026-09-04 | -4.37 |
| 2026-09-03 | -4.29 |
| 2026-09-02 | -4.36 |
| 2026-09-01 | -4.19 |
| 2026-08-31 | -4.12 |
| 2026-08-28 | -4.28 |
| 2026-08-27 | -4.35 |
| 2026-08-26 | -4.54 |
| 2026-08-25 | -4.59 |
| 2026-08-24 | -4.49 |
| 2026-08-21 | -4.62 |
| 2026-08-20 | -4.70 |
| 2026-08-19 | -4.89 |
| 2026-08-18 | -4.30 |
| 2026-08-17 | -4.24 |
| 2026-08-14 | -3.56 |
| 2026-08-13 | -3.40 |
| 2026-08-12 | -3.46 |
| 2026-08-11 | -3.35 |
| 2026-08-10 | -3.25 |
| 2026-08-07 | -3.14 |
| 2026-08-06 | -3.08 |
| 2026-08-05 | -3.00 |
| 2026-08-04 | -2.99 |
| 2026-08-03 | -2.94 |
| 2026-07-31 | -2.97 |
| 2026-07-30 | -2.94 |
| 2026-07-29 | -2.80 |
| 2026-07-28 | -2.87 |
| 2026-07-27 | -3.03 |
| 2026-07-24 | -2.94 |